Fig. 5

Inhibitory effect of GS-CDs on neuroblastoma in vivo. a Tumor growth of the mice tumors in the model (top), cisplatin (middle), and GS-CDs (bottom) group on the 1st, 5th, 9th, and 13th days as observed by CT scans (n = 3), where the scale bar was 1 cm. b Statistic charts showing the relative tumor volumes of the mice in the model, cisplatin and GS-CDs group, as calculated by the CT scans of the largest tumor sections. Data were mean ± s.d. (n = 3). c Photos of the dissected mice tumors in the model (top), cisplatin (middle) and GS-CDs (bottom) group at 13th day (n = 3), where the scale bar was 1 cm. d Statistic chart showing the tumor weight of the mice in the model, cisplatinand GS-CDs group. e Statistical weight diagrams of the mice in control, control + GS-CDs, model, cisplatin, and GS-CDs groups. Data were mean ± s.d. (n = 3). *p < 0.05, **p < 0.01 and ***p < 0.001 relative to the model group, as analyzed by one-way ANOVA.